Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 4.990
-0.070 (-1.38%)
At close: Aug 14, 2026
Read-Gene Revenue
Read-Gene had revenue of 4.17M PLN in the quarter ending June 30, 2026, with 21.59% growth. This brings the company's revenue in the last twelve months to 16.58M, up 10.34% year-over-year. In the year 2025, Read-Gene had annual revenue of 15.60M with 17.93% growth.
Revenue (ttm)
16.58M
Revenue Growth
+10.34%
P/S Ratio
3.56
Revenue / Employee
827.10K
Employees
20
Market Cap
58.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.60M | 2.37M | 17.93% |
| Dec 31, 2024 | 13.23M | 3.08M | 30.38% |
| Dec 31, 2023 | 10.15M | 2.91M | 40.13% |
| Dec 31, 2022 | 7.24M | 787.84K | 12.21% |
| Dec 31, 2021 | 6.45M | 377.23K | 6.21% |
| Dec 31, 2020 | 6.08M | 1.99M | 48.54% |
| Dec 31, 2019 | 4.09M | -722.06K | -15.00% |
| Dec 31, 2018 | 4.81M | 14.84K | 0.31% |
| Dec 31, 2017 | 4.80M | -403.96K | -7.77% |
| Dec 31, 2016 | 5.20M | 3.03M | 139.97% |
| Dec 31, 2015 | 2.17M | 1.43M | 193.82% |
| Dec 31, 2014 | 737.79K | 469.41K | 174.90% |
| Dec 31, 2013 | 268.38K | -248.40K | -48.07% |
| Dec 31, 2012 | 516.79K | 239.40K | 86.30% |
| Dec 31, 2011 | 277.39K | -86.25K | -23.72% |
| Dec 31, 2010 | 363.64K | -621.24K | -63.08% |
| Dec 31, 2009 | 984.88K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 583.14M |
| BioMaxima | 59.74M |
| Sygnis | 13.02M |
| Urteste | 2.50M |
| Pharmena | 1.61M |